Aardvark Therapeutics Adds Veteran Independent Board Director

An announcement from Aardvark Therapeutics, Inc. ( ) is now available. On October 7, 2026, Aardvark Therapeutics appointed David (Zhongwei) Zhang, Ph.D., MBA, as an independent Cl ...
BioSpace

Mineralys Therapeutics Announces Presentation of New Lorundrostat Data at the American Society of Nephrology (ASN) Kidney Week 2026

Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a biopharmaceutical company focused on developing medicines to target ...
Science

Nutritional interventions’ impacts on human milk: Three trials in low-resource settings

Human milk (HM) composition is variable to support changing infant needs and is influenced by maternal diet and health. We harmonized HM data from three randomized trials in Burkina Faso (MISAME-III), ...

Marvel Biosciences Signs Letter of Intent with Novatech for Phase 1 Trial of MB-204 and Provides Corporate Update

Marvel Biosciences Corp. (TSXV: MRVL | OTCQB: MBCOF), and its wholly-owned subsidiary, Marvel Biotechnology Inc. (collectively the “Company” or “Marvel”), a drug discovery company developing novel ...